𝔖 Bobbio Scriptorium
✦   LIBER   ✦

193 PROGNOSTIC SERUM BIOMARKERS FOR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION IN HEPATITIS C PATIENTS

✍ Scribed by P. Fytili; C. Brauner; A. Zapf; A.A. Negm; A. Gronert; V. Schlaphoff; H. Barg-Hock; C. Strassburg; F. Lehner; M. Cornberg; M.P. Manns; C. Falk; H. Wedemeyer

Book ID
117380405
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
62 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors of patient and graft survival
Predictors of patient and graft survival following liver transplantation for hepatitis C
✍ Michael Charlton; Eric Seaberg; Russell Wiesner; James Everhart; Rowen Zetterman πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L

Patient and graft survival in hepatitis
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States
✍ Mark W. Russo; Joseph Galanko; Kimberly Beavers; Michael W. Fried; Roshan Shrest πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

End stage liver disease from chronic hepatitis C is the leading indication for liver transplantation in the United States. Small studies suggest that recurrent hepatitis C may be more common and occur earlier after living donor liver transplantation compared to deceased donor liver transplantation.